Vertex Pharmaceuticals Incorporated (VRTX) — Fair Value Analysis
Base-case fair value (P50): $473.56 · Current price: $528.04 · Verdict: Fairly Valued
The Verdict on VRTX
Based on our Monte Carlo simulation, Vertex Pharmaceuticals Inc (VRTX) is currently Fairly Valued. The model indicates a median fair value (P50) of $473.56, standing at a -10.3% discount to the current market price of $528.04. This suggests that, from a probabilistic standpoint across thousands of forward scenarios, the market price largely aligns with the intrinsic value derived from a comprehensive range of financial forecasts. The -10.3% gap implies limited immediate upside potential from current levels.
How VRTX stacks up against peers
VRTX holds an average quality tier when assessing its operational and financial health against sector peers. While not an underperformer, this average quality rating provides context for the valuation. The Monte Carlo analysis, factoring in VRTX's fundamental profile, suggests that the market's current valuation of $528.04 accurately reflects this operational standing. An average quality tier combined with a median fair value of $473.56 points to a company priced reasonably given its current health and performance relative to its competitive landscape, with the -10.3% figure underscoring this equilibrium.
What this means for investors
Investors considering VRTX should note the "Fairly Valued" verdict from our Monte Carlo simulation. With a median fair value of $473.56 and a current price of $528.04, the -10.3% indicates that the stock is largely priced for its fundamentals. While an average quality tier suggests stable operational performance, the tight alignment between current price and median fair value implies that substantial immediate capital appreciation through a valuation gap closing is less probable. Despite this, FairCurve's simulations do identify potential bull and bear scenarios. Sign up for FairCurve to see the full bear/bull distribution and track VRTX's fair value as new fundamentals are released.
Frequently Asked Questions
Is VRTX overvalued or undervalued right now?
Based on our Monte Carlo simulations, VRTX is considered Fairly Valued, with a median fair value (P50) of $473.56 compared to its current price of $528.04.
What is the bear case and bull case for VRTX?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of upside, is available to subscribers with a free FairCurve account. We do not provide specific dollar values here.
How does FairCurve calculate VRTX's fair value?
FairCurve calculates VRTX's fair value using a sophisticated Monte Carlo simulation that models thousands of forward-looking financial scenarios to derive a probabilistic fair value range.
How can I track VRTX's fair value as it changes?
You can add VRTX to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation alerts whenever new earnings reports or significant fundamental data are released.